Skip to main content
NIH funding notice RFA-AG-22-030

Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)

Closed on January 10, 2022.

Posted
November 29, 2021
Close date
January 10, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,029,732 in first-year total cost, median $1,014,866.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 (A1)]2

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA-IRVINE1
  2. UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON1
Competing awards under RFA-AG-22-030 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD1U24AG079683-01GLABE, CHARLES G.HEAD, ELIZABETHUNIVERSITY OF CALIFORNIA-IRVINE, CA$1,265,234ZAG1
2022Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates1U24AG079685-01SOTO, CLAUDIOUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX$764,498ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-22-030: Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) | ScienceDex | ConductScience